Benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is a disease mainly caused by the disorder of sex hormone metabolism in the elderly, which leads to the proliferation of glands and (or) fibers and muscle tissues to varying degrees, resulting in an increase in the size of the prostate, destruction of normal structure and a series of functional disorders. Benign prostatic hyperplasia is a common disease in middle-aged and elderly men, and about half of men over 50 years old will have clinical symptoms. The enlarged prostate squeezes the urethra, leading to a series of urination disorders, such as frequent urination, urgency, weak urine flow, and incomplete urination. These symptoms seriously affect the patient's quality of life. Failure to treat them in time can lead to many serious complications (such as acute urinary retention, stones, renal insufficiency, etc.), and may even endanger the patient's life.
Related Drugs
Finasteride Tablets
Indication: Treats male pattern baldness (androgenetic alopecia), promoting hair growth and preventing further hair loss.
Manufacturer:
Topfond Pharmaceutical Co., Ltd.
Finasteride Tablets
Indication: 1. This product is suitable for the treatment of symptomatic benign prostatic hyperplasia (BPH). Improve symptoms. Reduce the risk of acute urinary retention. Reduce the risk of transurethral resection of the prostate (TURP) and prostatectomy. 2. It is suitable for the treatment of male baldness (androgenic alopecia), which can promote hair growth and prevent further hair loss.
Finasteride Tablets
Indication: This product is suitable for the treatment of symptomatic benign prostatic hyperplasia (BPH): 1. Improve symptoms. 2. Reduce the risk of acute urinary retention. 3. Reduce the risk of transurethral resection of the prostate (TURP) and prostatectomy.
Manufacturer:
Nanjing Haijing Pharmaceutical Co., Ltd.
Naftopidil Tablets
Indication: Used to relieve urinary tract obstruction symptoms caused by benign prostatic hyperplasia (BPH).
Manufacturer:
Bengbu Fengyuan Pharmaceutical Co., Ltd.
Naftopidil Tablets
Indication: 1. Used to slowly relieve urinary tract obstruction symptoms caused by benign prostatic hyperplasia (BPH). 2. Used for antihypertensive treatment of hypertension.
Manufacturer:
GUIZHOU-EAKAN Pharmaceutical Co., Ltd.
Naftopidil Tablets
Indication: Used to relieve urinary tract obstruction symptoms caused by benign prostatic hyperplasia (BPH).
Manufacturer:
Hubei Qianjiang Pharmaceutical Co., Ltd.
Naftopidil Tablets
Indication: Suitable for urination disorders caused by benign prostatic hyperplasia.
Manufacturer:
Nanjing Meirui Pharma Co., Ltd.
Naftopidil Tablets
Indication: 1. Used to relieve urinary tract obstruction symptoms caused by benign prostatic hyperplasia (BPH); 2. Used for antihypertensive treatment of hypertension.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Naftopidil Tablets
Indication: 1. Used to slowly relieve urinary tract obstruction symptoms caused by benign prostatic hyperplasia (BPH). 2. Used for antihypertensive treatment of hypertension.
Manufacturer:
GUIZHOU-EAKAN Pharmaceutical Co., Ltd.
Terazosin Hydrochloride Tablets
Indication: 1. Used to treat hypertension, and can be used alone or in combination with other antihypertensive drugs. 2. Used to improve urination symptoms in patients with benign prostatic hyperplasia, such as frequent urination, urgency, thinning of the urine stream, difficulty urinating, increased nocturia, and a feeling of incomplete urination.